Skip to main content

Posts

Showing posts with the label depression

ICD-11 Criteria for Current Depressive Episode Persistent

 Foundation URI : http://id.who.int/icd/entity/1906190365 ICD-11 Criteria for Current Depressive Episode Persistent 6A80.2 Description The diagnostic requirements for a depressive episode are currently met and have been met continuously for at least the past 2 years. Diagnostic Requirements This specifier can be applied if the diagnostic requirements for Depressive Episode are currently met and have been met continuously (five or more characteristic symptoms occurring most of the day, nearly every day) for at least the past 2 years. Reference: International Classification of Diseases Eleventh Revision (ICD-11). Geneva: World Health Organization; 2022. License: CC BY-ND 3.0 IGO. https://creativecommons.org/licenses/by-nc-nd/3.0/igo/

ICD-11 Criteria for Current Depressive Episode With Melancholia

ICD-11 Criteria for Current Depressive Episode With Melancholia 6A80.3 Description In the context of a current Depressive Episode, several of the following symptoms have been present during the worst period of the current episode: loss of interest or pleasure in most activities that are normally enjoyable to the individual (i.e., pervasive anhedonia); lack of emotional reactivity to normally pleasurable stimuli or circumstances (i.e., mood does not lift even transiently with exposure); terminal insomnia (i.e., waking in the morning two hours or more before the usual time); depressive symptoms are worse in the morning; marked psychomotor retardation or agitation; marked loss of appetite or loss of weight. Diagnostic Requirements This specifier can be applied if, in the context of a current Depressive Episode, several of the following symptoms have been present during the worst period of the current episode: Loss of interest or pleasure in most activities that are normally enjoyable to t

ICD-11 Criteria for Other Specified Depressive Disorders

ICD-11 Criteria for Other Specified Depressive Disorders 6A7Y  Essential (Required) Features: The presentation is characterized by mood symptoms that share primary clinical features with other Depressive Disorders (e.g., depressed mood, decreased engagement in pleasurable activities, decreased energy levels, disruptions in sleep or eating). The symptoms do not fulfil the diagnostic requirements for any other disorder in the Depressive Disorders grouping. The symptoms are not better accounted for by another Mental, Behavioural or Neurodevelopmental Disorder (e.g., Schizophrenia or Other Primary Psychotic Disorder, an Anxiety or Fear-Related Disorder, a Disorder Specifically Associated with Stress). The symptoms and behaviours are not a manifestation of another medical condition and are not due to the effects of a substance or medication (e.g., alcohol, benzodiazepine) on the central nervous system, including withdrawal effects (e.g., from cocaine). The symptoms result in significant dis

ICD-11 Criteria for Depression (Recurrent Depressive Disorder) 6A71

ICD-11 Criteria for Depression (Recurrent Depressive Disorder) 6A71 Recurrent depressive disorder is characterised by a history or at least two depressive episodes separated by at least several months without significant mood disturbance. A depressive episode is characterised by a period of depressed mood or diminished interest in activities occurring most of the day, nearly every day during a period lasting at least two weeks accompanied by other symptoms such as difficulty concentrating, feelings of worthlessness or excessive or inappropriate guilt, hopelessness, recurrent thoughts of death or suicide, changes in appetite or sleep, psychomotor agitation or retardation, and reduced energy or fatigue. There have never been any prior manic, hypomanic, or mixed episodes, which would indicate the presence of a Bipolar disorder. Inclusions:                Seasonal depressive disorder Exclusions:               Adjustment disorder (6B43) Bipolar or related disorders (BlockL2‑6A6) Sing

The Inventory of Depressive Symptoms and the Quick Inventory of Depressive Symptoms (IDS and QIDS)

The Inventory of Depressive Symptoms and the Quick Inventory of Depressive Symptoms (IDS and QIDS)   Rush et al., 1986; Rush, Gullion, Basco, Jarrett, & Trivedi, 1996; Rush et al., 2003). T he IDS/QIDS can be used as a screening tool; the QIDS is also appropriate to use as a diagnostic tool and to monitor symptom change over time (IDS-QIDS.org, 2013). The IDS/QIDS has not been used with adolescents, nor does a separate adolescent version exist. The IDS (30-item) and QIDS (16-item) are self- and clinician-report measures assessing depressive symptoms in adults. The briefer QIDS queries for only the nine major depressive disorder domains outlined in the Diagnostic and Statistical Manual of Mental Disorders 4 th ed, Text Revision (DSM-IVTR, American Psychiatric Association, 2010), where the IDS queries for these domains as well as associated symptoms such as anxiety and irritability. Each item is rated from zero (“does not feel sad”) to three (“feels intensely sad virtually all the t

Hamilton Rating Scale for Depression (HAM-D)

Hamilton Rating Scale for Depression (HAM-D) Hamilton, 1960. The HAM-D is a 17-item clinician-report measure assessing depressive symptoms in adults. The HAM-D can be used as a screening tool (Hamilton, 1960). There is disagreement in the literature regarding the HAM-D’s sensitivity to change and thus its appropriateness as a treatment monitoring tool. The HAM-D has been used in several studies with adolescents (e.g. Keller et al., 2001), but a separate adolescent version does not exist. Sample items include, “Depr e ssed mood” and “Feelings of guilt.” Eight symptoms are scored by severity on a zero to four scale, and eight symptoms are scored by intensity on a zero to two scale. The HAM-D is designed to be administered in 12 minutes and a structured interview guide can assist in scoring. The HAM-D demonstrates good internal consistency (α = .83), and adequate test-retest reliability over a period of four days ( r = .81). It demonstrates good to excellent inter-rater reliability (ICC

The Clinically Useful Depression Outcome Scale

The Clinically Useful Depression Outcome Scale (CUDOS) (Zimmerman, Chelminski, McGlinchey, & Posternak, 2008) The CUDOS can be used as a screening tool, a diagnostic tool (Zimmerman et al., 2008), and to monitor symptom changes over time (Zimmerman, McGlinchey, & Chelminski, 2008). The CUDOS has not been used with adolescents, nor does a separate adolescent version exist. The CUDOS is an 18-item self-report measure assessing depressive symptoms in adults. Sample items include, “I felt sad or depressed,”  “I was not as interested in my usual activities,” and “I felt guilty.” Each item is rated on a 5-point Likert scale indicating from zero (“not at all true/0 days”) to four (“almost always true/every day”). Total scores range from 0 to 64. The CUDOS was designed to be completed in less than three minutes and scored in less than 15 seconds. The CUDOS demonstrates excellent internal consistency (α = .90) and adequate test-retest reliability over a period of one week ( r > .92;

Neuropsychiatric lupus: a mosaic of clinical presentations

Neuropsychiatric lupus: a mosaic of clinical presentations Shaye Kivity 1,2,5† , Nancy Agmon-Levin 1,5† , Gisele Zandman-Goddard 3,5 , Joab Chapman 4,5  and Yehuda Shoenfeld 1,5,6,7* Abstract Neuropsychiatric symptoms affect nearly half of the patients with systemic lupus erythematosus; however, the effect on disease severity, quality of life, and the prognosis is tremendous. Symptoms of neuropsychiatric systemic lupus erythematosus may range from mild diffuse ones to acute life-threatening events. Although the underlying mechanisms are still largely unravelled, several pathogenic pathways are identified, such as antibody-mediated neurotoxicity, vasculopathy due to anti-phospholipid antibodies and other mechanisms, and cytokine-induced neurotoxicity. The current review describes the old and the new regarding epidemiology, pathophysiology, diagnosis, and management of neuropsychiatric systemic lupus erythematosus. The possible link between neuropsychiatric symptoms and specific mechanis